← 홈

Antibody · VEGF

234개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 234개
AntibodystaleRochePhase 2

Bevacizumab, docetaxel, cisplatin (Bevacizumab, docetaxel, cisplatin)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Bevacizumab,Trastuzumab,Paclitaxel,Cyclophosphamide,Myocet)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab-800CW (Bevacizumab-800CW)

Pancreatic Cancer; Pancreatic Adenocarcinoma · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Bevacizumab-awwb (Bevacizumab-awwb)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Bevacizumab； HRS-1167 (Bevacizumab； HRS-1167)

Recurrent Ovarian Cancer · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI (Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI)

Colorectal Cancer; Metastatic Colorectal Cancer With RAS Mutation · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

CAPOX combined with bevacizumab and Tislelizumab (CAPOX combined with bevacizumab and Tislelizumab)

Advanced Gastroesophageal Adenocarcinoma; First-line Therapy · Advanced Gastroesophageal Adenocarcinoma

#AdvancedGastroesophagealAdenocar#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

CAPOX+ Camrelizumab+ Bevacizumab (CAPOX+ Camrelizumab+ Bevacizumab)

Unresectable Metastatic Rectal Cancer; CAPOX · Unresectable Metastatic Rectal Cancer

#UnresectableMetastaticRectalCanc#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleProgen PharmaceuticalsPhase 1

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Cancer · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJiangsu HengruiPhase 2

Camrelizumab and Bevacizumab (Camrelizumab and Bevacizumab)

Recurrent Glioblastoma · Recurrent Glioblastoma

#RecurrentGlioblastoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSouth Eastern European Research…Phase 2

Capecitabine and Bevacizumab (Capecitabine and Bevacizumab)

Breast Cancer; Metastasis · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleCentre Francois BaclessePhase 2

atezolizumab (Tecentriq, Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab)

NSCLC Stage IIIB; NSCLC Stage IV · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
효능 ORR 42.9%임상시험 1상태 ACTIVE
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and paclitaxel plus atezolizumab and bevacizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPreclinical

trastuzumab (Herceptin, Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Cryoablation Combined with Tirelizumab and Bevacizumab (Cryoablation Combined with Tirelizumab and Bevacizumab)

Metastatic Breast Cancer in the Liver · Metastatic Breast Cancer in the Liver

#MetastaticBreastCancerintheLiver#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

Cyclophosphamide, Topotecan, and Bevacizumab (Cyclophosphamide, Topotecan, and Bevacizumab)

Neuroblastoma; Sarcoma · Neuroblastoma

#Neuroblastoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE

5 / 12 페이지

← 이전다음 →